🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Impressive phase 1 trial results testing a Claudin18.2-specific CAR in patients with R/R #GImalignancies. Favorable toxicity profile and correlation between T cell persistence and antitumor efficacy. Nature Medicine

Collaborators at Penn IBI and @YaleBME unveiled molecular mechanisms ⚙️ that may inform strategies to boost specific T cell function to maintain long-term remission in acute lymphoblastic #leukemia patients. MelenhorstLab Pablo G. Camara Rong Fan 📎 bit.ly/3xxOymd

Honored and humbled to be inducted to NAI. Believe in technology innovation for science, humanity, inclusion and patients! National Academy of Inventors #NAI2022

Interesting work from Scholler, Galon and colleagues on the baseline and post-CAR T cell treatment tumor microenvironment analysis. Plenty of material for mechanistic studies. Congrats to the team! nature.com/articles/s4159…

CAR-T Day in Lille France has been a wonderful meeting. Highly recommended! ⁦MelenhorstLab⁩ ⁦Paulos Lab⁩ ⁦Klebanoff_Lab⁩ ⁦Evan Weber⁩ #SumanMitra #JimKochenderfer #RobertaDiBlasi

Cleveland Clinic is selected as the leading healthcare system in a new initiative to accelerate collaboration and innovation in quantum computing. Developed by Connected DMV #QuantumWorldCongress, this hub leverages our partnership with IBM Research to advance medicine. cle.clinic/3UKK6dz

Applications open for a pediatric oncology physician scientist. Pediatric neuro-oncology focused clinical practice and laboratory program. Contact below to apply. Great opportunity to join a top cancer program. practicematch.com/physicians/job…

Excited to share TEMPOmap, our new spatiotemporal transcriptomics method that integrates metabolic labeling with 3D in situ sequencing to simultaneously profile the age and location of individual RNA molecules led by Rena Ren Haowen Zhou and Hu Zeng biorxiv.org/content/10.110…

I wouldn’t say “starting” but “advancing our understanding..”. Great progress with high translational potential! statnews.com/2022/10/04/why…

Bioicons.com Here is an alternative to BioRender that is TRULY FREE and actively maintained. Over 1500 vectorized images sorted by license type (all creative commons or MIT). Fully editable icons and soon they will launch an Inkscape library.

We are looking for doctors who are interested in Hematology and Oncology Hospitalist positions Cleveland Clinic practicematch.com/CareerCenter/O…

Nedd Brockmann: The man who ran across Australia in 47 days… Superman.. bbc.co.uk/news/world-aus…

North Korea tensions: Why is Kim Jong-un upping the pressure? Not so super, man! bbc.co.uk/news/world-asi…

Had my favorite book in my checked in luggage - which apparently left out in the rain. Now I am thinking again: buy the book or read this tortured copy? Thoughts?

Super excited to share the final publication of Spectra, fruit of the wonderful collaboration between Russell Zhang Kunes and Thomas Walle, a gene program factorization program that I hope will help many interpret and bring insight from their single-cell data -->

Super cool to see our work highlighted by ACIR If you haven’t had a chance to check it out yet this is a great summary!

Excited to share our latest work on an image analysis paradigm that combines cell state and morphology analyses of patient biopsies at single cell resolution to uncover clinically relevant head-and-neck #cancer phenotypes! Cell cell.com/cell/fulltext/… tweetorial👇

👏 Congrats to Prof. Carl June on receiving the The Abarca Prize! His pioneering work in CAR-T therapy has transformed cancer treatment. During my time in his lab, I had the chance to experience his inspiring vision and trust, for which I am deeply grateful. abarcaprize.com/award-winner-f…